首页 > 最新文献

Journal of midwifery & women's health最新文献

英文 中文
Research on Women's Health at the NIH and the Journal of Midwifery & Women's Health's Commitment to Evidence and Inclusion in Scholarship 美国国立卫生研究院的妇女健康研究以及助产和妇女健康杂志对证据和奖学金包容的承诺
IF 2.1 4区 医学 Q2 NURSING Pub Date : 2025-04-09 DOI: 10.1111/jmwh.13753
Melissa D. Avery CNM, PhD, Lisa Hanson CNM, PhD
<p>As the premier biomedical research funding agency in the United States, the National Institutes of Health (NIH) conducts intramural research and supports extramural research through 21 institutes and 5 centers.<span><sup>1</sup></span> Examples of funded studies that have contributed substantially to improved health outcomes include studies developing and testing innovative cancer treatments that inform treatment protocols.</p><p>The <i>NIH-Wide Strategic Plan for Women's Health Research</i> was published in December 2024.<span><sup>2</sup></span> This document provides a broad approach to guide scientists and others engaged in the federal enterprise for women's health research. Overall, the NIH commitment is to expanding knowledge about women's health across all disease states and health conditions, enhancing women's inclusion in clinical trials, examining how sex and gender influence health, and conducting research within a context of health across important life phases such as pregnancy and menopause. As experts in women's health, this document is valuable for midwifery researchers, clinicians, and policy experts alike.</p><p>The strategic plan is far-reaching, encompassing goals related to research, data systems, research training, basic and translational science, and community engagement. These goals emphasize the need to understand impacts of disease on women's health, including a focus on sex, gender, and health disparities, as well as social and cultural influences on women's health. The use of cutting-edge research methods, data analysis and interpretation, and evolving artificial intelligence tools is encouraged. Research training is recommended to focus on enhancing preparation of new researchers who will generate new knowledge about the impact of sex and gender on health, as well as increasing the number of women scientists conducting research. The enhancement of women's health research should also include understanding the influence of sex and gender on cellular function as well as system level physiologic processes, including those that are specific to pregnancy and menopause. The focus on community includes research training in community-engaged research approaches, implementation science, and a systemic approach to understanding how sex and gender impact women's health, including health disparities.<span><sup>2</sup></span></p><p>The NIH strategic goals for women's health research are important to research conducted by midwives and thus to midwifery practice. More midwives prepared to conduct research as principal investigators is critical to advancing the scholarly basis for our practice and model of care. Midwifery scientists, doctoral students, and postdoctoral fellows may find guidance in the strategic plan to inform their programs of research.</p><p>As we began to analyze the strategic plan to present its potential to guide midwives and midwifery research for the future, the very foundation of federal research funding of t
作为美国主要的生物医学研究资助机构,美国国立卫生研究院(NIH)通过21个研究所和5个中心开展校内研究并支持校外研究资助的研究对改善健康结果作出重大贡献的例子包括开发和测试创新的癌症治疗方法,为治疗方案提供信息。《美国国立卫生研究院妇女健康研究战略计划》于2024年12月发布。4.2该文件提供了一种广泛的方法,指导科学家和其他参与联邦妇女健康研究事业的人员。总体而言,美国国立卫生研究院的承诺是扩大对所有疾病状态和健康状况下妇女健康的了解,加强妇女在临床试验中的参与,检查性别和性别如何影响健康,并在怀孕和更年期等重要生命阶段的健康背景下开展研究。作为妇女健康方面的专家,这份文件对助产研究人员、临床医生和政策专家都很有价值。该战略计划意义深远,包括与研究、数据系统、研究培训、基础科学和转化科学以及社区参与有关的目标。这些目标强调需要了解疾病对妇女健康的影响,包括注重性别、性别和健康差异,以及社会和文化对妇女健康的影响。鼓励使用尖端的研究方法、数据分析和解释以及不断发展的人工智能工具。建议研究培训的重点是加强培养新的研究人员,他们将产生关于性和社会性别对健康的影响的新知识,并增加从事研究的女科学家的人数。加强妇女健康研究还应包括了解性别和社会性别对细胞功能和系统一级生理过程的影响,包括与怀孕和更年期有关的生理过程。以社区为重点的工作包括对社区参与的研究方法进行研究培训、实施科学以及采用系统方法了解性别和社会性别如何影响妇女健康,包括健康差异。2 .国家卫生研究院妇女健康研究的战略目标对助产士进行的研究和助产实践都很重要。更多的助产士准备作为主要调查人员进行研究,这对于推进我们的实践和护理模式的学术基础至关重要。助产学科学家、博士生和博士后可以在战略计划中找到指导,为他们的研究项目提供信息。当我们开始分析这一战略计划,以展示其指导未来助产士和助产学研究的潜力时,美国国立卫生研究院联邦研究基金的基础受到了质疑。在写这篇文章的时候,NIH的研究基金被冻结了3 .取消了2025年第一次审查拨款提案的研究所咨询委员会会议2025年2月7日,在新的行政领导下,美国国立卫生研究院发布了一项政策声明,将新的和未来拨款的间接成本从研究总直接成本的约50%降低到15%间接费用是一种行政补充,用于支持机构基础设施,如建筑物和实验室、用品和设备,以及拨款和预算管理人员。间接费用的大幅度减少威胁到大学和其他研究机构继续开展工作的能力。4,5黑人和土著居民与白人相比在健康结果方面存在差异,其根源在于种族主义和歧视以及社会和经济不平等。6,7因此,许多当代妇女健康研究的目标和范围都是设法解决这些问题,以改善结果。2025年1月的行政命令指示联邦机构“协调终止所有歧视性计划,包括非法DEI和‘多样性,公平,包容和可及性’ (DEIA)联邦政府的任务,政策,计划,偏好和活动,无论其名称如何。”8(p1)本行政命令旨在扭转最终取得重大进展的联邦政策。紧随其后的是食品和药物管理局关于药物和医疗器械临床试验要求的指导文件被取消,以包括来自代表性不足的种族和族裔人口的研究参与者另一项关于性别的行政命令宣布,性别必须列出男性或女性,不得要求性别认同,并删除了关于跨性别平等的指导文件,指出联邦资金不能用于宣传性别意识形态。
{"title":"Research on Women's Health at the NIH and the Journal of Midwifery & Women's Health's Commitment to Evidence and Inclusion in Scholarship","authors":"Melissa D. Avery CNM, PhD,&nbsp;Lisa Hanson CNM, PhD","doi":"10.1111/jmwh.13753","DOIUrl":"https://doi.org/10.1111/jmwh.13753","url":null,"abstract":"&lt;p&gt;As the premier biomedical research funding agency in the United States, the National Institutes of Health (NIH) conducts intramural research and supports extramural research through 21 institutes and 5 centers.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; Examples of funded studies that have contributed substantially to improved health outcomes include studies developing and testing innovative cancer treatments that inform treatment protocols.&lt;/p&gt;&lt;p&gt;The &lt;i&gt;NIH-Wide Strategic Plan for Women's Health Research&lt;/i&gt; was published in December 2024.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; This document provides a broad approach to guide scientists and others engaged in the federal enterprise for women's health research. Overall, the NIH commitment is to expanding knowledge about women's health across all disease states and health conditions, enhancing women's inclusion in clinical trials, examining how sex and gender influence health, and conducting research within a context of health across important life phases such as pregnancy and menopause. As experts in women's health, this document is valuable for midwifery researchers, clinicians, and policy experts alike.&lt;/p&gt;&lt;p&gt;The strategic plan is far-reaching, encompassing goals related to research, data systems, research training, basic and translational science, and community engagement. These goals emphasize the need to understand impacts of disease on women's health, including a focus on sex, gender, and health disparities, as well as social and cultural influences on women's health. The use of cutting-edge research methods, data analysis and interpretation, and evolving artificial intelligence tools is encouraged. Research training is recommended to focus on enhancing preparation of new researchers who will generate new knowledge about the impact of sex and gender on health, as well as increasing the number of women scientists conducting research. The enhancement of women's health research should also include understanding the influence of sex and gender on cellular function as well as system level physiologic processes, including those that are specific to pregnancy and menopause. The focus on community includes research training in community-engaged research approaches, implementation science, and a systemic approach to understanding how sex and gender impact women's health, including health disparities.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;The NIH strategic goals for women's health research are important to research conducted by midwives and thus to midwifery practice. More midwives prepared to conduct research as principal investigators is critical to advancing the scholarly basis for our practice and model of care. Midwifery scientists, doctoral students, and postdoctoral fellows may find guidance in the strategic plan to inform their programs of research.&lt;/p&gt;&lt;p&gt;As we began to analyze the strategic plan to present its potential to guide midwives and midwifery research for the future, the very foundation of federal research funding of t","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 2","pages":"197-199"},"PeriodicalIF":2.1,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jmwh.13753","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143801319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perinatal Substance Use Disorder Educational Content in US Midwifery Training Programs: A Survey 美国助产培训计划中的围产期物质使用障碍教育内容:一项调查。
IF 2.3 4区 医学 Q2 NURSING Pub Date : 2025-04-07 DOI: 10.1111/jmwh.13755
Meagan Thompson CNM, DNP, APRN, PMHNP-BC, Casey Tak PhD, Jessica Ann Ellis CNM, PhD, APRN, Melissa Saftner CNM, PhD, APRN

Introduction

Perinatal substance use disorders (PSUDs) are a leading cause of maternal mortality and morbidity during the pregnancy and postpartum periods. This study aims to assess the incorporation of PSUD training in midwifery education programs and provide actionable recommendations for enhancing midwifery training.

Methods

A cross-sectional survey was administered to US certified nurse-midwifery and certified midwifery education program directors regarding the didactic and clinical education their students received.

Results

There were 35 of 39 programs that responded to the survey. Findings indicate that most midwifery programs provide didactic content, but less than half of midwifery programs provide clinical experiences for their students. Most programs provide didactic content covering nicotine and tobacco cessation, perinatal alcohol use, epidemiology of substance use disorders, and screening for substance use disorders.

Discussion

Program directors identified several barriers to enhanced PSUD education and clinical experience for their students, including lack of dedicated perinatal addiction clinicians, lack of faculty expertise, lack of time in the curriculum, and lack of time by faculty, among others.

围产期物质使用障碍(PSUDs)是妊娠和产后期间孕产妇死亡和发病的主要原因。本研究旨在评估PSUD培训在助产教育计划中的纳入情况,并为加强助产培训提供可操作的建议。方法:对美国注册助产护士和注册助产教育项目主任进行横断面调查,了解其学生接受的教学和临床教育情况。结果:39个项目中有35个回应了调查。研究结果表明,大多数助产学课程提供教学内容,但不到一半的助产学课程为学生提供临床经验。大多数项目提供的教学内容包括尼古丁和戒烟,围产期酒精使用,物质使用障碍的流行病学,以及物质使用障碍的筛查。讨论:项目主管确定了几个障碍,以加强PSUD教育和临床经验,为他们的学生,包括缺乏专门的围产期成瘾临床医生,缺乏教师的专业知识,缺乏时间在课程中,缺乏教师的时间,等等。
{"title":"Perinatal Substance Use Disorder Educational Content in US Midwifery Training Programs: A Survey","authors":"Meagan Thompson CNM, DNP, APRN, PMHNP-BC,&nbsp;Casey Tak PhD,&nbsp;Jessica Ann Ellis CNM, PhD, APRN,&nbsp;Melissa Saftner CNM, PhD, APRN","doi":"10.1111/jmwh.13755","DOIUrl":"10.1111/jmwh.13755","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Perinatal substance use disorders (PSUDs) are a leading cause of maternal mortality and morbidity during the pregnancy and postpartum periods. This study aims to assess the incorporation of PSUD training in midwifery education programs and provide actionable recommendations for enhancing midwifery training.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A cross-sectional survey was administered to US certified nurse-midwifery and certified midwifery education program directors regarding the didactic and clinical education their students received.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There were 35 of 39 programs that responded to the survey. Findings indicate that most midwifery programs provide didactic content, but less than half of midwifery programs provide clinical experiences for their students. Most programs provide didactic content covering nicotine and tobacco cessation, perinatal alcohol use, epidemiology of substance use disorders, and screening for substance use disorders.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>Program directors identified several barriers to enhanced PSUD education and clinical experience for their students, including lack of dedicated perinatal addiction clinicians, lack of faculty expertise, lack of time in the curriculum, and lack of time by faculty, among others.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 4","pages":"624-628"},"PeriodicalIF":2.3,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143797460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Reviews to Inform Practice, March/April 2025 为实践提供依据的系统性评论》,2025 年 3 月/4 月刊
IF 2.1 4区 医学 Q2 NURSING Pub Date : 2025-04-01 DOI: 10.1111/jmwh.13756
Nena R. Harris CNM, PhD, FNP-BC, CNE, Abby Howe-Heyman CNM, PhD
<p>Age-related pregnancy outcomes on both ends of the childbearing spectrum can reflect differences in risk factors for certain maternal or neonatal conditions. Congenital anomalies include structural and functional defects that develop during pregnancy and are the most common cause of neonatal and infant morbidity and mortality.<sup>1</sup> Although numerous research studies have demonstrated a relationship between advanced maternal age and chromosomal anomalies, data on the association with nonchromosomal congenital anomalies (NCAs) have provided inconsistent findings.<span><sup>1</sup></span><sup>,</sup><span><sup>2</sup></span> For example, a 2017 study found no association between maternal age and major congenital anomalies and may reflect an “all or nothing”<span><sup>3</sup></span><sup>(p 221)</sup> survival of fetuses with normal anatomy. Furthermore, studies examining very young maternal age (<20 years) is limited and have indicated associations with a limited number of birth defects, namely those of the abdominal wall.<span><sup>4</sup></span> Population data demonstrating increased maternal age at birth in recent decades warrant a closer look at the role of maternal age in the prevalence of NCAs.<span><sup>5-7</sup></span></p><p>Recognizing that no previous meta-analysis has specifically examined the relationship between maternal age and NCAs, Pethő et al<span><sup>1</sup></span> conducted a systematic review and meta-analysis to explore maternal age as a key factor in occurrence of NCAs. The study protocol was submitted to the International Prospective Register of Systematic Reviews. They included studies that collected data on associations between maternal age and congenital anomalies. They excluded studies that highlighted chromosomal anomalies as well as case reports and cohort and case control studies. The authors hypothesized that very young and more advanced ages would be associated with higher rates of NCAs.</p><p>Their analysis was based on 72 population-based studies conducted from 1967 through 2021 with population sizes ranging from 4220 to almost 25 million. Most studies were from the United States (n = 29), European countries (n = 14), China (n = 7), and Canada (n = 4), with the remaining from countries throughout Southeast Asia, South America, Australia, and other regions. The authors compared age groups <20, 30 to 35, >35, and >40 years with the reference group of age 20 to 30 years. The prevalence of NCAs was the primary outcome of the analysis; secondary outcomes included defects of various organ systems and common birth defects.</p><p>Accounting for all NCAs, the authors found an increased risk of all studied NCAs due to age >35 (risk ratio [RR], 1.31; 95% CI, 1.07-1.61) and, notably, age >40 (RR, 1.44; 95% CI,1.25-1.66). The increased risk of total NCAs for age >40 years was significant when examined individually without the influencing effects of chromosomal anomalies (RR, 1.25; 95% CI, 1.08-1.4
与年龄相关的妊娠结局在生育谱的两端可以反映某些产妇或新生儿疾病的风险因素的差异。先天性畸形包括在怀孕期间形成的结构和功能缺陷,是新生儿和婴儿发病和死亡的最常见原因尽管许多研究已经证明高龄产妇与染色体异常之间存在关系,但与非染色体先天性异常(NCAs)相关的数据提供了不一致的结果。例如,2017年的一项研究发现,母亲年龄与重大先天性异常之间没有关联,这可能反映了解剖结构正常的胎儿的“全有或全无”存活。此外,研究非常年轻的母亲年龄(20岁)是有限的,并表明与有限数量的出生缺陷有关,即腹壁缺陷人口数据显示,近几十年来产妇的出生年龄有所增加,因此有必要更仔细地研究产妇年龄在NCAs患病率中的作用。5-7认识到之前没有meta分析专门研究过产妇年龄与NCAs之间的关系,petheren等人1进行了系统回顾和meta分析,以探讨产妇年龄是NCAs发生的关键因素。该研究方案已提交给国际前瞻性系统评价登记册。其中包括收集母亲年龄与先天性异常之间关联数据的研究。他们排除了强调染色体异常的研究,以及病例报告、队列和病例对照研究。作者假设,年龄越小和年龄越高,nca的发病率越高。他们的分析基于1967年至2021年进行的72项基于人口的研究,人口规模从4220万到近2500万不等。大多数研究来自美国(n = 29)、欧洲国家(n = 14)、中国(n = 7)和加拿大(n = 4),其余研究来自东南亚、南美、澳大利亚等地区的国家。作者将20岁、30岁到35岁、35岁和40岁年龄组与20岁到30岁的参照组进行了比较。NCAs的患病率是分析的主要结果;次要结果包括各种器官系统缺陷和常见的出生缺陷。考虑到所有的NCAs,作者发现所有研究的NCAs因年龄而增加的风险[RR], 35(风险比[RR], 1.31;95% CI, 1.07-1.61),尤其是年龄(RR, 1.44;95%可信区间,1.25 - -1.66)。在没有染色体异常影响的情况下,单独检查40岁时NCAs总风险增加是显著的(RR, 1.25;95% ci, 1.08-1.46)。当染色体异常和NCAs一起考虑时,35岁产妇NCAs的风险高1.26倍(95% CI, 1.12-1.42), 40岁产妇NCAs的风险高1.63倍(95% CI, 1.26-2.09),风险随年龄的增加而增加。在40岁年龄组中,循环系统NCAs的风险增加了近2倍(RR, 1.94;95% ci, 1.28-2.93)。对于先天性心脏缺陷,从35岁开始,风险增加了1.5倍(95% CI, 1.11-2.04), 40岁时风险进一步增加(RR, 1.75;95% ci, 1.32-2.32)。20岁的年轻母亲对先天性心脏缺陷有保护作用(RR, 0.87;95% ci, 0.78-0.97)。与40岁相关的其他异常包括唇裂和腭裂(RR, 1.57;95% CI, 1.11-2.20),消化系统异常(RR, 2.16;95% CI, 1.34-3.49)和脐膨出(RR, 2.57;95% ci, 1.77-3.73)。发生脐膨出的风险(RR, 1.44;95% CI, 1.08-1.92)和胃裂(RR, 3.08;95% CI, 2.74-3.47)也与年龄相关。没有发现年龄对泌尿系统、神经系统和肌肉骨骼系统异常的影响,也没有足够的研究提供数据来检测眼睛、耳朵、面部、颈部、呼吸系统和生殖器的nca与年龄的相关性。该分析的优势包括研究的时间跨度和地理位置。此外,所有研究的偏倚风险为低至中等,大多数研究被认为是高质量的。与之前的荟萃分析相比,作者还研究了更小的年龄亚组。局限性包括纳入研究的回顾性设计、样本量的显著差异和测量结果的异质性。作者还指出,纳入研究的时间跨度以及报告和筛查方面的相关差异可能是导致异质性的因素。然而,本荟萃分析提供了一些有用的见解,关于产妇出生年龄的趋势和与NCAs的关系。 随着越来越多的高龄产妇怀孕,有必要采取识别异常的策略,以便及时采取干预措施。非染色体异常的诊断依赖于解剖缺陷的可视化,而在妊娠诊断测试中提供的绒毛膜绒毛取样和羊膜穿刺术选择错过了这些。虽然提供这些诊断选择是目前的标准护理,当出生年龄为35岁时,目前没有建议仅根据母亲年龄增加超声监测,或在妊娠后期完成目前的常规胎儿解剖超声筛查,因为许多非染色体异常更明显,诊断更准确。营养缺乏和缺乏对叶酸补充的认识可能在年轻孕妇的NCAs中起作用照顾20岁以下和35岁以上患者的医疗服务提供者应该参与共同决策,以调整筛查方案,其中可能包括增加超声解剖扫描
{"title":"Systematic Reviews to Inform Practice, March/April 2025","authors":"Nena R. Harris CNM, PhD, FNP-BC, CNE,&nbsp;Abby Howe-Heyman CNM, PhD","doi":"10.1111/jmwh.13756","DOIUrl":"https://doi.org/10.1111/jmwh.13756","url":null,"abstract":"&lt;p&gt;Age-related pregnancy outcomes on both ends of the childbearing spectrum can reflect differences in risk factors for certain maternal or neonatal conditions. Congenital anomalies include structural and functional defects that develop during pregnancy and are the most common cause of neonatal and infant morbidity and mortality.&lt;sup&gt;1&lt;/sup&gt; Although numerous research studies have demonstrated a relationship between advanced maternal age and chromosomal anomalies, data on the association with nonchromosomal congenital anomalies (NCAs) have provided inconsistent findings.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;sup&gt;,&lt;/sup&gt;&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; For example, a 2017 study found no association between maternal age and major congenital anomalies and may reflect an “all or nothing”&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;sup&gt;(p 221)&lt;/sup&gt; survival of fetuses with normal anatomy. Furthermore, studies examining very young maternal age (&lt;20 years) is limited and have indicated associations with a limited number of birth defects, namely those of the abdominal wall.&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt; Population data demonstrating increased maternal age at birth in recent decades warrant a closer look at the role of maternal age in the prevalence of NCAs.&lt;span&gt;&lt;sup&gt;5-7&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Recognizing that no previous meta-analysis has specifically examined the relationship between maternal age and NCAs, Pethő et al&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; conducted a systematic review and meta-analysis to explore maternal age as a key factor in occurrence of NCAs. The study protocol was submitted to the International Prospective Register of Systematic Reviews. They included studies that collected data on associations between maternal age and congenital anomalies. They excluded studies that highlighted chromosomal anomalies as well as case reports and cohort and case control studies. The authors hypothesized that very young and more advanced ages would be associated with higher rates of NCAs.&lt;/p&gt;&lt;p&gt;Their analysis was based on 72 population-based studies conducted from 1967 through 2021 with population sizes ranging from 4220 to almost 25 million. Most studies were from the United States (n = 29), European countries (n = 14), China (n = 7), and Canada (n = 4), with the remaining from countries throughout Southeast Asia, South America, Australia, and other regions. The authors compared age groups &lt;20, 30 to 35, &gt;35, and &gt;40 years with the reference group of age 20 to 30 years. The prevalence of NCAs was the primary outcome of the analysis; secondary outcomes included defects of various organ systems and common birth defects.&lt;/p&gt;&lt;p&gt;Accounting for all NCAs, the authors found an increased risk of all studied NCAs due to age &gt;35 (risk ratio [RR], 1.31; 95% CI, 1.07-1.61) and, notably, age &gt;40 (RR, 1.44; 95% CI,1.25-1.66). The increased risk of total NCAs for age &gt;40 years was significant when examined individually without the influencing effects of chromosomal anomalies (RR, 1.25; 95% CI, 1.08-1.4","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 2","pages":"362-374"},"PeriodicalIF":2.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jmwh.13756","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143801323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research and Professional Literature to Inform Practice, March/April 2025 研究和专业文献为实践提供信息,2025年3 / 4月
IF 2.1 4区 医学 Q2 NURSING Pub Date : 2025-03-30 DOI: 10.1111/jmwh.13750
Amy Alspaugh CNM, PhD, MSN
{"title":"Research and Professional Literature to Inform Practice, March/April 2025","authors":"Amy Alspaugh CNM, PhD, MSN","doi":"10.1111/jmwh.13750","DOIUrl":"https://doi.org/10.1111/jmwh.13750","url":null,"abstract":"","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 2","pages":"356-361"},"PeriodicalIF":2.1,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jmwh.13750","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143801731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provider-Led Interventions to Reduce Congenital Cytomegalovirus 提供者主导的干预措施减少先天性巨细胞病毒。
IF 2.3 4区 医学 Q2 NURSING Pub Date : 2025-03-28 DOI: 10.1111/jmwh.13749
Erin Trisko CNM, MS, Kayla Gosnell CNM, MS, Taneesha Douglas CNM, MS, MBA, Katrina Wu CNM, PhD

Introduction

Cytomegalovirus (CMV) infection immediately before or during pregnancy can infect a fetus transplacentally, causing congenital CMV (cCMV). cCMV can cause miscarriage, stillbirth, growth restriction, neurodevelopmental delay, hearing, and vision impairment. This integrative review examined original research to better inform health care providers on methods for reducing cCMV infections.

Methods

Database searching to identify original research pertaining to cCMV prevention in CINAHL, PubMed, and Nursing and Allied Health in January 2024 produced an initial 417 initial studies. Final extraction included 34 studies that met inclusion criteria for analysis.

Results

Three relevant themes emerged: education, screening, and treatment. Messaging and education focused on risk reduction as most effective for behavioral changes. Maternal screening did not predict cCMV in low-risk women; however, it did diagnose early-stage maternal infections. Initiation of treatment closer to infection diagnosis demonstrated better outcomes. The 2 main treatment options for maternal infection were valacyclovir 8 g daily orally and CMV-hyperimmunoglobulin (HIG) 100 or 200 units per kilogram via intravenous (IV) infusion at varying frequency. Research on the efficacy of valacyclovir showed reductions in the incidence of cCMV without adverse maternal effects. Reduction in neonatal transmission and adverse sequelae were more likely with the 200 units per kilogram dosing of IV administration of HIG-CMV compared with the lower dose of 100 units per kilogram.

Discussion

cCMV is often overlooked and untreated. Education in a variety of formats is effective at increasing provider knowledge and reducing infection rates by influencing maternal behavior. Screening recommendations are inconsistent but can be used as a tool to identify those pregnant individuals at highest risk, which could facilitate early diagnosis and prompt treatment. Maternal administration of medications such as valacyclovir and HIG-CMV have been shown to reduce the incidence of cCMV. Treatment options for CMV infection in pregnancy and resources for patient education are available and can reduce transmission to the neonate.

导语:巨细胞病毒(CMV)在妊娠前或妊娠期间感染可经胎盘感染胎儿,引起先天性巨细胞病毒(cCMV)。cCMV可导致流产、死产、生长受限、神经发育迟缓、听力和视力损害。本综合综述检查了原始研究,以更好地告知卫生保健提供者减少cCMV感染的方法。方法:检索数据库以确定2024年1月在CINAHL、PubMed和护理与联合健康中有关cCMV预防的原始研究,产生了最初的417项初步研究。最终提取符合纳入标准的34项研究进行分析。结果:出现了三个相关主题:教育、筛查和治疗。信息和教育的重点是减少风险,这是行为改变的最有效方法。产妇筛查不能预测低危妇女的cCMV;然而,它确实诊断出了早期母体感染。在更接近感染诊断时开始治疗显示出更好的结果。母体感染的两种主要治疗方案是每日口服瓦昔洛韦8g和不同频率静脉输注巨细胞病毒高免疫球蛋白(HIG)每公斤100或200单位。对valacyclovir疗效的研究表明,cCMV发病率降低,且对母体无不良影响。与每公斤100单位的较低剂量相比,每公斤200单位的静脉给药更有可能减少新生儿传播和不良后遗症。讨论:cCMV经常被忽视和未经治疗。通过影响产妇行为,各种形式的教育在增加提供者知识和降低感染率方面是有效的。筛查建议不一致,但可作为识别风险最高的孕妇个体的工具,有助于早期诊断和及时治疗。孕妇服用药物如valacyclovir和high - cmv已被证明可以降低cCMV的发生率。妊娠期巨细胞病毒感染的治疗方案和患者教育资源是可用的,可以减少传播给新生儿。
{"title":"Provider-Led Interventions to Reduce Congenital Cytomegalovirus","authors":"Erin Trisko CNM, MS,&nbsp;Kayla Gosnell CNM, MS,&nbsp;Taneesha Douglas CNM, MS, MBA,&nbsp;Katrina Wu CNM, PhD","doi":"10.1111/jmwh.13749","DOIUrl":"10.1111/jmwh.13749","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Cytomegalovirus (CMV) infection immediately before or during pregnancy can infect a fetus transplacentally, causing congenital CMV (cCMV). cCMV can cause miscarriage, stillbirth, growth restriction, neurodevelopmental delay, hearing, and vision impairment. This integrative review examined original research to better inform health care providers on methods for reducing cCMV infections.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Database searching to identify original research pertaining to cCMV prevention in CINAHL, PubMed, and Nursing and Allied Health in January 2024 produced an initial 417 initial studies. Final extraction included 34 studies that met inclusion criteria for analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Three relevant themes emerged: education, screening, and treatment. Messaging and education focused on risk reduction as most effective for behavioral changes. Maternal screening did not predict cCMV in low-risk women; however, it did diagnose early-stage maternal infections. Initiation of treatment closer to infection diagnosis demonstrated better outcomes. The 2 main treatment options for maternal infection were valacyclovir 8 g daily orally and CMV-hyperimmunoglobulin (HIG) 100 or 200 units per kilogram via intravenous (IV) infusion at varying frequency. Research on the efficacy of valacyclovir showed reductions in the incidence of cCMV without adverse maternal effects. Reduction in neonatal transmission and adverse sequelae were more likely with the 200 units per kilogram dosing of IV administration of HIG-CMV compared with the lower dose of 100 units per kilogram.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>cCMV is often overlooked and untreated. Education in a variety of formats is effective at increasing provider knowledge and reducing infection rates by influencing maternal behavior. Screening recommendations are inconsistent but can be used as a tool to identify those pregnant individuals at highest risk, which could facilitate early diagnosis and prompt treatment. Maternal administration of medications such as valacyclovir and HIG-CMV have been shown to reduce the incidence of cCMV. Treatment options for CMV infection in pregnancy and resources for patient education are available and can reduce transmission to the neonate.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 4","pages":"576-592"},"PeriodicalIF":2.3,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jmwh.13749","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choosing Where to Give Birth 选择在哪里分娩
IF 2.1 4区 医学 Q2 NURSING Pub Date : 2025-03-26 DOI: 10.1111/jmwh.13751

Everyone has the right to give birth in a safe place where they feel comfortable. You can choose to give birth at home, in a birth center, or in a hospital. The decision is an important one based on your health and preferences. Talk to your provider about benefits and risks to you and your baby based on your chosen birth setting.

If you choose a home birth, you will have regular visits with a midwife during your pregnancy. Sometimes they will come to your home for the visits. Sometimes you may go to an office or clinic. When your labor begins, the midwife will come to your home. You will need to prepare your home for the birth. This includes getting some supplies. The midwife will bring the needed birthing equipment and a few medications to care for you and your baby. The midwife and another person trained in newborn care will be present when you give birth. The midwife will usually stay for several hours after your baby is born to make sure you are both doing well.

A birth center is a home-like space set up for labor and birth. Birth centers may be freestanding (in a building or house located away from a hospital) or attached to a hospital. Your prenatal visits and birth will occur with a midwife at the birth center. They will provide the supplies, equipment, and medications you might need. You usually stay in the birth center for several hours after you give birth.

Most people in the United States give birth in a hospital even if they are healthy. Hospitals offer different types of care during pregnancy. Some hospitals have separate areas for labor and postpartum care. Others have special rooms where a person can labor, give birth, and then stay until they go home. A tour of the hospital's labor and delivery area and discussion with the staff will help you find out what services your hospital offers.

You may want to consider costs of each setting and what services your insurance will cover. The following lists can help you choose the birth setting that is best for you.

Key Differences in the 3 Birth Settings

Flesch-Kincaid Reading level 7.2

Approved February 2025. Replaces “Choosing Where to Give Birth” published in Volume 61, Issue 2, March/April 2016

This handout may be reproduced for noncommercial use by health care professionals to share with patients, but modifications to the handout are not permitted. The information and recommendations in this handout are not a substitute for health care. Consult your health care provider for information specific to you and your health.

每个人都有权在自己感到舒适的安全场所分娩。您可以选择在家中、分娩中心或医院分娩。根据您的健康状况和喜好来决定是非常重要的。如果您选择在家分娩,助产士会在您怀孕期间定期拜访您。有时助产士会上门服务。有时助产士会到办公室或诊所。当您开始分娩时,助产士会来到您的家中。您需要在家中为分娩做好准备。这包括准备一些用品。助产士会带来所需的分娩设备和一些药物来照顾您和宝宝。助产士和另一位受过新生儿护理培训的人员会在您分娩时在场。助产士通常会在您的宝宝出生后停留几个小时,以确保您和宝宝都状况良好。分娩中心可以是独立的(在远离医院的建筑物或房屋内),也可以是附属于医院的。助产士将在分娩中心为您进行产前检查和分娩。他们会提供您可能需要的用品、设备和药物。分娩后,您通常会在分娩中心待上几个小时。在美国,即使身体健康,大多数人也会在医院分娩。医院在孕期提供不同类型的护理。有些医院有单独的分娩区和产后护理区。还有一些医院有专门的房间,产妇可以在那里分娩、生产,然后一直待到回家。参观医院的产房和分娩区以及与工作人员讨论将有助于您了解医院提供哪些服务。以下列表可以帮助您选择最适合您的分娩环境。三种分娩环境的主要区别 Flesch-Kincaid 阅读级别 7.22025 年 2 月批准。取代2016年3月/4月第61卷第2期发表的《选择在哪里分娩》本讲义可由医疗保健专业人员复制用于非商业目的,与患者分享,但不允许对讲义进行修改。本手册中的信息和建议不能替代医疗保健。有关您和您的健康状况的具体信息,请咨询您的医疗服务提供者。
{"title":"Choosing Where to Give Birth","authors":"","doi":"10.1111/jmwh.13751","DOIUrl":"https://doi.org/10.1111/jmwh.13751","url":null,"abstract":"<p>Everyone has the right to give birth in a safe place where they feel comfortable. You can choose to give birth at home, in a birth center, or in a hospital. The decision is an important one based on your health and preferences. Talk to your provider about benefits and risks to you and your baby based on your chosen birth setting.</p><p>If you choose a home birth, you will have regular visits with a midwife during your pregnancy. Sometimes they will come to your home for the visits. Sometimes you may go to an office or clinic. When your labor begins, the midwife will come to your home. You will need to prepare your home for the birth. This includes getting some supplies. The midwife will bring the needed birthing equipment and a few medications to care for you and your baby. The midwife and another person trained in newborn care will be present when you give birth. The midwife will usually stay for several hours after your baby is born to make sure you are both doing well.</p><p>A birth center is a home-like space set up for labor and birth. Birth centers may be freestanding (in a building or house located away from a hospital) or attached to a hospital. Your prenatal visits and birth will occur with a midwife at the birth center. They will provide the supplies, equipment, and medications you might need. You usually stay in the birth center for several hours after you give birth.</p><p>Most people in the United States give birth in a hospital even if they are healthy. Hospitals offer different types of care during pregnancy. Some hospitals have separate areas for labor and postpartum care. Others have special rooms where a person can labor, give birth, and then stay until they go home. A tour of the hospital's labor and delivery area and discussion with the staff will help you find out what services your hospital offers.</p><p>You may want to consider costs of each setting and what services your insurance will cover. The following lists can help you choose the birth setting that is best for you.</p><p><b>Key Differences in the 3 Birth Settings</b>\u0000 \u0000 </p><p>Flesch-Kincaid Reading level 7.2</p><p>Approved February 2025. Replaces “Choosing Where to Give Birth” published in Volume 61, Issue 2, March/April 2016</p><p>This handout may be reproduced for noncommercial use by health care professionals to share with patients, but modifications to the handout are not permitted. The information and recommendations in this handout are not a substitute for health care. Consult your health care provider for information specific to you and your health.</p>","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 2","pages":"377-378"},"PeriodicalIF":2.1,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jmwh.13751","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143801368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effects of Interventions During Pregnancy to Improve Breastfeeding Self-Efficacy: Systematic Review and Meta-Analysis 孕期干预对提高母乳喂养自我效能的影响:系统回顾和荟萃分析。
IF 2.3 4区 医学 Q2 NURSING Pub Date : 2025-03-24 DOI: 10.1111/jmwh.13742
Fatma Koruk PhD, MSN, BSN, Selma Kahraman PhD, MSN, BSN, Zeliha Turan PhD, MSN, BSN, Hatice Nur Özgen MSN, BSN, Burcu Beyazgül MD, PhD
<div> <section> <h3> Introduction</h3> <p>Breastfeeding self-efficacy can be increased through effective interventions to improve breastfeeding rates and promote maternal and infant health. Improving breastfeeding self-efficacy in the prenatal period is important for successful breastfeeding and sustainable breastfeeding practices after birth. Although randomized controlled trials have shown that antenatal and postnatal interventions can boost breastfeeding self-efficacy, evidence is lacking on which interventions are most effective and on the key characteristics of such interventions. The purpose of this review was (1) to examine the effects of various antenatal interventions on breastfeeding self-efficacy and (2) to identify the most effective intervention.</p> </section> <section> <h3> Methods</h3> <p>In this meta-analysis, randomized controlled trials and experimental studies were searched using 5 search engines in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocols declaration guidelines. In total, 34 studies were identified, which included 4698 participants. A random effects model, subgroup analysis, and meta-regression analysis were used to pool the results.</p> </section> <section> <h3> Results</h3> <p>During pregnancy, all types of interventions except model-based counseling provided without prior education and simulation methods have been effective in increasing breastfeeding self-efficacy (<i>P</i> <.05). Intervention type was the only intervention characteristic that showed statistically significant differences in effect size using the between-group heterogeneity statistic (Q<sub>B</sub>, 13.888; <i>P</i> = .016). A meta-regression analysis found a significant effect of differences in intervention types across studies (heterogeneity: τ<sup>2</sup>, 0.672; Q value = 662.100; <i>df</i> = 33; <i>P</i> < .001; <i>I<sup>2</sup></i> = 95.016%; test for overall effect: z, 7.020; <i>P</i> = .001), and this difference was found to be due to model-based education and counseling, which had the largest effect size in increasing breastfeeding self-efficacy. Intervention type explained 16% of the relationship between interventions to increase breastfeeding self-efficacy during pregnancy and breastfeeding self-efficacy (<i>r<sup>2</sup></i> = 0.16).</p> </section> <section> <h3> Discussion</h3> <p>There is a relationship between the types of interventions for breastfeeding during pregnancy and breastfeeding self-efficacy. To increase breastfeeding self-efficacy during pregnancy, it is recommended that health care
通过有效的干预措施,可以提高母乳喂养自我效能感,提高母乳喂养率,促进母婴健康。提高产前母乳喂养的自我效能感对于成功的母乳喂养和产后可持续的母乳喂养做法非常重要。尽管随机对照试验表明,产前和产后干预可以提高母乳喂养的自我效能感,但缺乏证据表明哪些干预措施最有效,以及这些干预措施的关键特征。本综述的目的是:(1)检查各种产前干预对母乳喂养自我效能的影响;(2)确定最有效的干预措施。方法:在本荟萃分析中,根据系统评价和荟萃分析方案声明指南的首选报告项目,使用5个搜索引擎检索随机对照试验和实验研究。总共确定了34项研究,其中包括4698名参与者。采用随机效应模型、亚组分析和元回归分析对结果进行汇总。结果:在妊娠期,除基于模型的咨询外,在没有事先教育和模拟方法的情况下,所有类型的干预措施都能有效提高母乳喂养自我效能感(P B, 13.888;P = .016)。meta回归分析发现,不同研究的干预类型差异有显著影响(异质性:τ2, 0.672;Q值= 662.100;Df = 33;P 2 = 95.016%;整体效果检验:z, 7.020;P = .001),这种差异是由于基于模型的教育和咨询,这对提高母乳喂养自我效能感的影响最大。干预类型对孕期母乳喂养自我效能感与母乳喂养自我效能感之间的关系解释了16% (r2 = 0.16)。讨论:妊娠期母乳喂养干预类型与母乳喂养自我效能感之间存在关系。为了提高怀孕期间母乳喂养的自我效能感,建议卫生保健专业人员主要制定包括基于模型的教育和咨询在内的计划。
{"title":"The Effects of Interventions During Pregnancy to Improve Breastfeeding Self-Efficacy: Systematic Review and Meta-Analysis","authors":"Fatma Koruk PhD, MSN, BSN,&nbsp;Selma Kahraman PhD, MSN, BSN,&nbsp;Zeliha Turan PhD, MSN, BSN,&nbsp;Hatice Nur Özgen MSN, BSN,&nbsp;Burcu Beyazgül MD, PhD","doi":"10.1111/jmwh.13742","DOIUrl":"10.1111/jmwh.13742","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Introduction&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Breastfeeding self-efficacy can be increased through effective interventions to improve breastfeeding rates and promote maternal and infant health. Improving breastfeeding self-efficacy in the prenatal period is important for successful breastfeeding and sustainable breastfeeding practices after birth. Although randomized controlled trials have shown that antenatal and postnatal interventions can boost breastfeeding self-efficacy, evidence is lacking on which interventions are most effective and on the key characteristics of such interventions. The purpose of this review was (1) to examine the effects of various antenatal interventions on breastfeeding self-efficacy and (2) to identify the most effective intervention.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;In this meta-analysis, randomized controlled trials and experimental studies were searched using 5 search engines in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocols declaration guidelines. In total, 34 studies were identified, which included 4698 participants. A random effects model, subgroup analysis, and meta-regression analysis were used to pool the results.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;During pregnancy, all types of interventions except model-based counseling provided without prior education and simulation methods have been effective in increasing breastfeeding self-efficacy (&lt;i&gt;P&lt;/i&gt; &lt;.05). Intervention type was the only intervention characteristic that showed statistically significant differences in effect size using the between-group heterogeneity statistic (Q&lt;sub&gt;B&lt;/sub&gt;, 13.888; &lt;i&gt;P&lt;/i&gt; = .016). A meta-regression analysis found a significant effect of differences in intervention types across studies (heterogeneity: τ&lt;sup&gt;2&lt;/sup&gt;, 0.672; Q value = 662.100; &lt;i&gt;df&lt;/i&gt; = 33; &lt;i&gt;P&lt;/i&gt; &lt; .001; &lt;i&gt;I&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt; = 95.016%; test for overall effect: z, 7.020; &lt;i&gt;P&lt;/i&gt; = .001), and this difference was found to be due to model-based education and counseling, which had the largest effect size in increasing breastfeeding self-efficacy. Intervention type explained 16% of the relationship between interventions to increase breastfeeding self-efficacy during pregnancy and breastfeeding self-efficacy (&lt;i&gt;r&lt;sup&gt;2&lt;/sup&gt;&lt;/i&gt; = 0.16).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Discussion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;There is a relationship between the types of interventions for breastfeeding during pregnancy and breastfeeding self-efficacy. To increase breastfeeding self-efficacy during pregnancy, it is recommended that health care ","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 4","pages":"610-623"},"PeriodicalIF":2.3,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jmwh.13742","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143702543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perinatal Health Care Preferences in a Rural Mennonite Community: A Mixed-Methods Study 农村门诺派社区围产期保健偏好:一项混合方法研究。
IF 2.3 4区 医学 Q2 NURSING Pub Date : 2025-03-20 DOI: 10.1111/jmwh.13746
April E. Ward CNM, DM, MSN, Barbara K. Hackley CNM, PhD, Emily C. McGahey CNM, DM, MSN

Introduction

A rapidly growing rural community of Old Order Mennonites in upstate New York abruptly lost midwifery services in 2018, causing a crisis in perinatal care access. A mixed-methods study was undertaken to explore health status, perinatal needs, and preferences in this culturally homogenous group.

Methods

An anonymous survey mailed to 650 Mennonite families assessed demographic characteristics, general health, perinatal optimality, perinatal care characteristics, stress and anxiety related to rural childbearing, and preferences for a perinatal health care system. Voluntary follow-up telephone interviews explored recent perinatal experiences and desires for future care.

Results

Surveys were returned by 218 Mennonite women, a 33.5% response rate. Home birth was preferred by 94.6% of participants. The mean (SD) Perinatal Background Index score was 86.7% (11.7), indicating a high level of optimality. Elevated levels of stress and anxiety, as measured by the Rural Pregnancy Experience Scale, were reported by 12 participants (6.6%). Qualitative descriptive analysis of 21 interviews revealed a strong desire to preserve home birth, receive care that was respectful of Mennonite cultural norms, and maintain a personal choice of birth attendants.

Discussion

According to participants, an ideal perinatal care system would ensure locally available, skilled midwives willing to maintain the community's traditional childbearing practices. Despite rural remoteness, distance from inpatient perinatal services was not associated with increased stress and anxiety. Access to care could be improved by state-level initiatives to expand the licensure of midwives and to remove barriers to birth center development.

导读:2018年,纽约州北部一个快速发展的旧秩序门诺派农村社区突然失去了助产服务,导致围产期护理机会危机。一项混合方法研究进行了探索健康状况,围产期需求,并在这一文化同质群体的偏好。方法:邮寄给650个门诺派家庭进行匿名调查,评估人口统计学特征、一般健康状况、围产期最佳状态、围产期护理特征、与农村生育有关的压力和焦虑,以及对围产期保健系统的偏好。自愿随访电话访谈探讨了近期围产期经历和对未来护理的期望。结果:218名门诺派女性参与了调查,回复率为33.5%。94.6%的参与者选择在家分娩。平均(SD)围产期背景指数评分为86.7%(11.7),显示出较高的优化水平。据农村怀孕体验量表测量,有12名参与者(6.6%)报告压力和焦虑水平升高。对21个访谈的定性描述分析显示,人们强烈希望保留在家分娩,接受尊重门诺文化规范的护理,并保留个人选择的助产士。讨论:与会者认为,一个理想的围产期护理系统将确保当地有熟练的助产士愿意维持社区的传统生育做法。尽管地处偏远,但与住院围产期服务的距离与压力和焦虑的增加无关。可以通过州一级的举措来改善获得护理的机会,以扩大助产士的执照,并消除生育中心发展的障碍。
{"title":"Perinatal Health Care Preferences in a Rural Mennonite Community: A Mixed-Methods Study","authors":"April E. Ward CNM, DM, MSN,&nbsp;Barbara K. Hackley CNM, PhD,&nbsp;Emily C. McGahey CNM, DM, MSN","doi":"10.1111/jmwh.13746","DOIUrl":"10.1111/jmwh.13746","url":null,"abstract":"<div>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>A rapidly growing rural community of Old Order Mennonites in upstate New York abruptly lost midwifery services in 2018, causing a crisis in perinatal care access. A mixed-methods study was undertaken to explore health status, perinatal needs, and preferences in this culturally homogenous group.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An anonymous survey mailed to 650 Mennonite families assessed demographic characteristics, general health, perinatal optimality, perinatal care characteristics, stress and anxiety related to rural childbearing, and preferences for a perinatal health care system. Voluntary follow-up telephone interviews explored recent perinatal experiences and desires for future care.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Surveys were returned by 218 Mennonite women, a 33.5% response rate. Home birth was preferred by 94.6% of participants. The mean (SD) Perinatal Background Index score was 86.7% (11.7), indicating a high level of optimality. Elevated levels of stress and anxiety, as measured by the Rural Pregnancy Experience Scale, were reported by 12 participants (6.6%). Qualitative descriptive analysis of 21 interviews revealed a strong desire to preserve home birth, receive care that was respectful of Mennonite cultural norms, and maintain a personal choice of birth attendants.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>According to participants, an ideal perinatal care system would ensure locally available, skilled midwives willing to maintain the community's traditional childbearing practices. Despite rural remoteness, distance from inpatient perinatal services was not associated with increased stress and anxiety. Access to care could be improved by state-level initiatives to expand the licensure of midwives and to remove barriers to birth center development.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 4","pages":"602-609"},"PeriodicalIF":2.3,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143665738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral Health During Pregnancy 孕期口腔健康
IF 2.1 4区 医学 Q2 NURSING Pub Date : 2025-03-20 DOI: 10.1111/jmwh.13752

Oral health, the health of your teeth and gums, is important before, during, and after pregnancy. Normal changes that occur during pregnancy can affect the teeth and gums. These include hormone changes, nausea and vomiting, and changes in your diet and lifestyle.

During pregnancy, the placenta releases the hormones progesterone and estrogen. The increases in these hormones can cause changes in your mouth. This can lead to swelling or bleeding of the gums, loosening of the teeth, and increases in saliva. Progesterone and estrogen increase the risk of infection, cavities, and damage to the structures that support the teeth. Changes to the immune system during pregnancy increase the chance of infections that can affect the health of teeth and gums. Most issues can be prevented if you take good care of your mouth and will go away after the birth of the baby. However, if you have severe problems with your mouth before pregnancy, they may get worse and need more treatment.

Dental care during pregnancy is safe and recommended to improve oral and general health. Most people don't get the treatment they need. It is also important for your baby's health. Teeth cleaning, dental x-rays, and most dental treatments can be safely done when you are pregnant. Make sure your dentist knows that you are pregnant. If medications for infection or pain are needed, your dentist can prescribe safe choices for you and your baby. Tell your dentist or health care provider about any changes in your mouth, teeth, or gums you have noticed since you became pregnant. Your dentist will determine if x-rays are needed. Your belly should be covered with a lead apron during x-rays to protect you and your baby.

Flesch-Kincaid Grade Level: 6.6

Approved February 2025. This handout replaces “Dental Care in Pregnancy” published in Volume 59, Number 1, January/February 2014 and “Oral Health: Keeping Your Mouth Clean and Healthy” published in Volume 56, Number 2, March/April 2011.

This handout may be reproduced for noncommercial use by health care professionals to share with patients, but modifications to the handout are not permitted. The information and recommendations in this handout are not a substitute for health care. Consult your health care provider for information specific to you and your health.

口腔健康,牙齿和牙龈的健康,在怀孕前、怀孕期间和怀孕后都很重要。怀孕期间发生的正常变化会影响牙齿和牙龈。这些包括激素变化、恶心和呕吐、饮食和生活方式的改变。在怀孕期间,胎盘会释放黄体酮和雌激素。这些激素的增加会导致口腔的变化。这会导致牙龈肿胀或出血,牙齿松动,唾液增多。黄体酮和雌激素会增加感染、蛀牙和破坏支撑牙齿的结构的风险。怀孕期间免疫系统的变化会增加感染的机会,从而影响牙齿和牙龈的健康。如果你照顾好你的口腔,大多数问题都是可以预防的,并且在宝宝出生后就会消失。然而,如果你在怀孕前有严重的口腔问题,它们可能会变得更糟,需要更多的治疗。怀孕期间的牙齿护理是安全的,建议改善口腔和全身健康。大多数人没有得到他们需要的治疗。这对宝宝的健康也很重要。当你怀孕时,洗牙、牙科x光和大多数牙科治疗都是安全的。确保你的牙医知道你怀孕了。如果需要治疗感染或疼痛的药物,牙医会为你和宝宝开出安全的处方。告诉你的牙医或健康护理人员你怀孕后发现的口腔、牙齿或牙龈的任何变化。你的牙医会决定是否需要x光。在做x光检查时,你的腹部应该用铅围裙盖住,以保护你和你的宝宝。Flesch-Kincaid等级:6.6 2025年2月批准。本讲义取代了2014年1月/ 2月出版的第59卷第1期《孕期牙齿护理》和2011年3月/ 4月出版的第56卷第2期《口腔健康:保持口腔清洁和健康》。本讲义可以复制用于非商业用途,供卫生保健专业人员与患者分享,但不允许对讲义进行修改。本讲义中的信息和建议不能替代医疗保健。向您的医疗保健提供者咨询有关您和您的健康的具体信息。
{"title":"Oral Health During Pregnancy","authors":"","doi":"10.1111/jmwh.13752","DOIUrl":"https://doi.org/10.1111/jmwh.13752","url":null,"abstract":"<p>Oral health, the health of your teeth and gums, is important before, during, and after pregnancy. Normal changes that occur during pregnancy can affect the teeth and gums. These include hormone changes, nausea and vomiting, and changes in your diet and lifestyle.</p><p>During pregnancy, the placenta releases the hormones progesterone and estrogen. The increases in these hormones can cause changes in your mouth. This can lead to swelling or bleeding of the gums, loosening of the teeth, and increases in saliva. Progesterone and estrogen increase the risk of infection, cavities, and damage to the structures that support the teeth. Changes to the immune system during pregnancy increase the chance of infections that can affect the health of teeth and gums. Most issues can be prevented if you take good care of your mouth and will go away after the birth of the baby. However, if you have severe problems with your mouth before pregnancy, they may get worse and need more treatment.</p><p>Dental care during pregnancy is safe and recommended to improve oral and general health. Most people don't get the treatment they need. It is also important for your baby's health. Teeth cleaning, dental x-rays, and most dental treatments can be safely done when you are pregnant. Make sure your dentist knows that you are pregnant. If medications for infection or pain are needed, your dentist can prescribe safe choices for you and your baby. Tell your dentist or health care provider about any changes in your mouth, teeth, or gums you have noticed since you became pregnant. Your dentist will determine if x-rays are needed. Your belly should be covered with a lead apron during x-rays to protect you and your baby.</p><p>Flesch-Kincaid Grade Level: 6.6</p><p>Approved February 2025. This handout replaces “Dental Care in Pregnancy” published in Volume 59, Number 1, January/February 2014 and “Oral Health: Keeping Your Mouth Clean and Healthy” published in Volume 56, Number 2, March/April 2011.</p><p>This handout may be reproduced for noncommercial use by health care professionals to share with patients, but modifications to the handout are not permitted. The information and recommendations in this handout are not a substitute for health care. Consult your health care provider for information specific to you and your health.</p>","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 2","pages":"375-376"},"PeriodicalIF":2.1,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jmwh.13752","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143801433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing Type 2 Diabetes in Women With Gestational Diabetes: Three Theoretical Perspectives on Behavior Change 妊娠期糖尿病妇女预防2型糖尿病:行为改变的三个理论视角
IF 2.3 4区 医学 Q2 NURSING Pub Date : 2025-03-20 DOI: 10.1111/jmwh.13747
Lotte Elton MBBS, MSc, MPhil, Ann-Kristin Porth MD, Julie L. O'Sullivan PhD, Jan C. Zoellick PhD, Paul Gellert PhD, Andy Guise PhD, Alexandra Kautzky-Willer MD, PhD

Gestational diabetes (GDM) affects 1 in 6 pregnancies worldwide1 and around a third of those diagnosed with GDM will develop Type 2 diabetes mellitus (T2DM) within 15 years.2 Follow-up care for people with GDM therefore offers an opportunity to detect blood glucose abnormalities early and reduce the risk of T2DM complications.2 Recommendations for postpartum GDM care focus on glucose testing and health education for lifestyle changes.3 Guidelines recommend that people with GDM should undergo glucose testing with an oral glucose tolerance test or with hemoglobin A1c (HbA1c) at 6 to 12 weeks postpartum to exclude T2DM. HbA1c or fasting glucose testing at regular 1 to 3 year intervals is advised to identify progression to T2DM.3 People diagnosed with GDM should be offered lifestyle advice on weight control, diet, and exercise, which may be delivered via structured education programs.3

Although guidelines emphasize the importance of providing follow-up care to people with prior GDM,3 this care is often lacking. A recent editorial in The Lancet highlights the slow progress made in implementing GDM follow-up care, despite its potential to improve long-term cardiometabolic health.4 Uptake of glucose screening is poor globally, with only a third of people with prior GDM receiving regular screening as recommended.5 Barriers to screening include a lack of clear guidance about T2DM risk, competing responsibilities such as work or childcare, and poor continuity between pregnancy and primary care services.6 Behavioral interventions for T2DM prevention have also had mixed success.7 Only 2 of 13 controlled trials regarding lifestyle interventions for people with prior GDM showed significant reduction in T2DM, and there is evidence of publication bias.8 All this suggests that postpartum glucose screening and education interventions have not had the desired effect.

Public health interventions are complex, involving multiple stakeholders and unpredictable outcomes. One way to understand and improve these interventions is by using theory: frameworks of ideas or concepts to explain how something works or why something happens. Theoretical frameworks can help policymakers and health care professionals understand the behavior of key stakeholders, identify appropriate strategies for change, and predict possible outcomes. By incorporating social, psychological, and behavioral factors, theory provides useful insight when developing new interventions or assessing why existing ones have not been successful. However, interventions for T2DM prevention in people with GDM often lack theoretical grounding, and few studies specify a theoretical framework for their interventi

妊娠期糖尿病(GDM)影响全球六分之一的孕妇1,约三分之一的妊娠期糖尿病患者将在15年内发展为2型糖尿病(T2DM)因此,对GDM患者的后续护理提供了早期发现血糖异常和降低T2DM并发症风险的机会建议产后护理以血糖检测和生活方式改变的健康教育为重点指南建议GDM患者应在产后6 - 12周进行口服糖耐量试验或糖化血红蛋白(HbA1c)血糖检测,以排除T2DM。建议每隔1至3年定期进行糖化血红蛋白或空腹血糖检测,以确定是否进展为t2dm被诊断为GDM的人应该提供关于体重控制、饮食和运动的生活方式建议,这些建议可以通过有组织的教育项目来提供。虽然指南强调对既往GDM患者提供随访护理的重要性,但这种护理往往是缺乏的。《柳叶刀》杂志最近的一篇社论强调,尽管GDM有改善长期心脏代谢健康的潜力,但在实施GDM随访护理方面进展缓慢在全球范围内,葡萄糖筛查的使用率很低,只有三分之一的既往GDM患者按照建议接受定期筛查筛查的障碍包括缺乏关于2型糖尿病风险的明确指导,工作或照顾孩子等竞争性责任,以及怀孕和初级保健服务之间的连续性差预防2型糖尿病的行为干预也取得了不同程度的成功在13项对照试验中,只有2项对既往GDM患者进行生活方式干预,结果显示T2DM显著降低,有证据表明存在发表偏倚所有这些都表明,产后血糖筛查和教育干预并没有达到预期的效果。公共卫生干预措施是复杂的,涉及多个利益攸关方和不可预测的结果。理解和改进这些干预措施的一种方法是使用理论:用思想或概念的框架来解释事物如何运作或为什么会发生。理论框架可以帮助决策者和卫生保健专业人员了解关键利益相关者的行为,确定适当的变革战略,并预测可能的结果。通过结合社会、心理和行为因素,理论在开发新的干预措施或评估现有干预措施不成功的原因时提供了有用的见解。然而,对GDM患者预防2型糖尿病的干预措施往往缺乏理论依据,很少有研究为其干预制定理论框架。本文探讨了GDM随访中的挑战,并通过借鉴健康心理学和社会学的3个理论框架来考虑解决方案:健康行动过程方法(HAPA), Link和Phelan的病耻感理论,以及Bourdieu的社会实践理论对于有效预防2型糖尿病所需的行为改变,每种理论都提供了不同但互补的观点。我们建议建立更健全、有理论基础的GDM随访护理模型,以改善产后代谢健康,降低T2DM风险。这里概述的三个理论框架强调了行为改变的不同方面。HAPA模型提供了关于如何支持人们克服个人行为改变障碍的见解,但忽略了他们做出决定的社会环境。社会实践理论通过强调个人的信仰、感受和行为如何受到更广泛的社会结构的影响而增加了背景。通过运用社会实践理论,卫生保健提供者可以将HAPA中概述的心理因素(如行动自我效能)理解为依赖于资源的获取。耻感理论整合了个体因素和结构因素,展示了某些个体的耻辱如何塑造他们的行为并影响他们的社会地位。依赖于行为改变的2型糖尿病干预必须帮助个人在其生活、家庭和社会网络的背景下做出这些改变。GDM随访护理途径应该是无障碍的,旨在使人们更容易参与卫生保健,并消除参加预约或实验室筛查的障碍。考虑因素可能包括现场托儿,从妊娠护理到初级保健提供者的自动转诊,以及在产后助产士或儿科预约时提供葡萄糖检测。一个很好的例子是美国妇产科学院最近建议,GDM患者应该在出生住院期间(而不是4-12周后)进行第一次产后血糖筛查,以最大限度地参与。即使在怀孕后仍被认为有风险,可能会加重GDM对人们自我形象的负面影响。 同样,定期筛查可能会加剧健康焦虑和耻辱感。挑战在于制定有效的干预措施,同时确保受援者不感到受到侮辱。如有可能,应避免将GDM患者隔离到单独的产前或产后服务中。T2DM生活方式教育和血糖筛查可纳入产后初级保健预约,T2DM预防可采取全家庭积极健康促进的形式。在设计T2DM预防方案时,考虑患者的习惯和资源获取是至关重要的。至少,应将教育水平和社会经济地位等健康的社会决定因素纳入任何2型糖尿病预防规划的评估,以确定健康结果或获得服务方面的不平等。许多生活方式干预的研究没有报告或调整这些因素那些设计干预措施或照顾GDM患者的人必须考虑到耻辱和社会排斥是阻碍接受筛查和采取更健康行为的关键因素。这里讨论的理论可以帮助卫生专业人员了解患者的行为,包括为什么他们可能不参与预防2型糖尿病的努力,并考虑如何更好地支持患者。2型糖尿病的预防是一项多学科的责任,应该由初级保健提供者、助产士和产科医生共同考虑,从受GDM影响的妊娠早期开始。助产士与妊娠期GDM患者密切相关,但在GDM护理的开创性评论或指南中未被提及。因此,调查显示,只有一半的助产士在产后访问期间筛查既往GDM患者预防2型糖尿病的干预措施应包括整个围产期跨专业团队,并考虑如何在妊娠和产后护理中嵌入健康促进。在设计预防GDM患者发生2型糖尿病的干预措施时,重要的是要认识到人们改变行为的动机和意愿是由他们的经历和社会文化背景决定的。为了取得成功,干预措施应该承认人们的健康信念和行为是长期社会、文化和历史叙述的一部分。卫生保健专业人员在预防2型糖尿病方面可以发挥重要作用:例如,通过帮助个人制定针对其社会文化背景的行动计划,或通过倡导获得文化上适当的教育资源。从理论的角度来看,接近公共卫生干预使政策制定者和卫生保健专业人员认识到影响健康行为的复杂相互作用,并揭示最适合干预的机制。我们提出的三种理论方法为GDM随访护理可能不成功的原因提供了见解,并为今后如何改善GDM患者的产后护理提供了建议。作者没有需要披露的利益冲突。
{"title":"Preventing Type 2 Diabetes in Women With Gestational Diabetes: Three Theoretical Perspectives on Behavior Change","authors":"Lotte Elton MBBS, MSc, MPhil,&nbsp;Ann-Kristin Porth MD,&nbsp;Julie L. O'Sullivan PhD,&nbsp;Jan C. Zoellick PhD,&nbsp;Paul Gellert PhD,&nbsp;Andy Guise PhD,&nbsp;Alexandra Kautzky-Willer MD, PhD","doi":"10.1111/jmwh.13747","DOIUrl":"10.1111/jmwh.13747","url":null,"abstract":"<p>Gestational diabetes (GDM) affects 1 in 6 pregnancies worldwide<span><sup>1</sup></span> and around a third of those diagnosed with GDM will develop Type 2 diabetes mellitus (T2DM) within 15 years.<span><sup>2</sup></span> Follow-up care for people with GDM therefore offers an opportunity to detect blood glucose abnormalities early and reduce the risk of T2DM complications.<span><sup>2</sup></span> Recommendations for postpartum GDM care focus on glucose testing and health education for lifestyle changes.<span><sup>3</sup></span> Guidelines recommend that people with GDM should undergo glucose testing with an oral glucose tolerance test or with hemoglobin A1c (HbA1c) at 6 to 12 weeks postpartum to exclude T2DM. HbA1c or fasting glucose testing at regular 1 to 3 year intervals is advised to identify progression to T2DM.<span><sup>3</sup></span> People diagnosed with GDM should be offered lifestyle advice on weight control, diet, and exercise, which may be delivered via structured education programs.<span><sup>3</sup></span></p><p>Although guidelines emphasize the importance of providing follow-up care to people with prior GDM,<span><sup>3</sup></span> this care is often lacking. A recent editorial in <i>The Lancet</i> highlights the slow progress made in implementing GDM follow-up care, despite its potential to improve long-term cardiometabolic health.<span><sup>4</sup></span> Uptake of glucose screening is poor globally, with only a third of people with prior GDM receiving regular screening as recommended.<span><sup>5</sup></span> Barriers to screening include a lack of clear guidance about T2DM risk, competing responsibilities such as work or childcare, and poor continuity between pregnancy and primary care services.<span><sup>6</sup></span> Behavioral interventions for T2DM prevention have also had mixed success.<span><sup>7</sup></span> Only 2 of 13 controlled trials regarding lifestyle interventions for people with prior GDM showed significant reduction in T2DM, and there is evidence of publication bias.<span><sup>8</sup></span> All this suggests that postpartum glucose screening and education interventions have not had the desired effect.</p><p>Public health interventions are complex, involving multiple stakeholders and unpredictable outcomes. One way to understand and improve these interventions is by using theory: frameworks of ideas or concepts to explain how something works or why something happens. Theoretical frameworks can help policymakers and health care professionals understand the behavior of key stakeholders, identify appropriate strategies for change, and predict possible outcomes. By incorporating social, psychological, and behavioral factors, theory provides useful insight when developing new interventions or assessing why existing ones have not been successful. However, interventions for T2DM prevention in people with GDM often lack theoretical grounding, and few studies specify a theoretical framework for their interventi","PeriodicalId":16468,"journal":{"name":"Journal of midwifery & women's health","volume":"70 4","pages":"545-548"},"PeriodicalIF":2.3,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jmwh.13747","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143665739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of midwifery & women's health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1